Literature DB >> 8954130

Retinoic acid receptors beta and gamma distinguish retinoid signals for growth inhibition and neuritogenesis in human neuroblastoma cells.

B Cheung1, J E Hocker, S A Smith, U Reichert, M D Norris, M Haber, B W Stewart, G M Marshall.   

Abstract

Retinoids induce marked growth inhibition and neuritic differentiation in human neuroblastoma cells. Expression patterns of nuclear retinoic acid receptors (RAR) in embryonic and adult tissues suggests that RAR subtypes alpha, beta and gamma have tissue-specific functions. We have transfected a human neuroblastoma tumor cell line with a vector expressing either human RAR alpha, beta or gamma cDNAs. In the absence of exogenous retinoid, RAR beta transfectants demonstrated marked growth inhibition without morphologic evidence of differentiation, whereas transfectant clones overexpressing RARs alpha and gamma had no significant reduction in cell growth rates. Although RAR gamma transfectants were sensitive to the growth inhibitory effects of exogenous retinoids, these cells demonstrated resistance to the neuritogenic retinoid effects. Only RAR beta transfectants exhibited increased sensitivity to retinoids added in vitro. These results suggest that distinct neuritogenic and growth inhibitory signalling pathways exist in neuroblastoma cells and that RAR beta expression may be necessary for the retinoid growth inhibitory pathway.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8954130     DOI: 10.1006/bbrc.1996.1804

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  3 in total

1.  The retinoid signalling molecule, TRIM16, is repressed during squamous cell carcinoma skin carcinogenesis in vivo and reduces skin cancer cell migration in vitro.

Authors:  Belamy B Cheung; Jessica Koach; Owen Tan; Patrick Kim; Jessica L Bell; Carla D'andreti; Selina Sutton; Alena Malyukova; Eric Sekyere; Murray Norris; Michelle Haber; Maria Kavallaris; Anne M Cunningham; Charlotte Proby; Irene Leigh; James S Wilmott; Caroline L Cooper; Gary M Halliday; Richard A Scolyer; Glenn M Marshall
Journal:  J Pathol       Date:  2011-10-18       Impact factor: 7.996

Review 2.  Why Differentiation Therapy Sometimes Fails: Molecular Mechanisms of Resistance to Retinoids.

Authors:  Petr Chlapek; Viera Slavikova; Pavel Mazanek; Jaroslav Sterba; Renata Veselska
Journal:  Int J Mol Sci       Date:  2018-01-03       Impact factor: 5.923

3.  ATP7A is a novel target of retinoic acid receptor beta2 in neuroblastoma cells.

Authors:  A Bohlken; B B Cheung; J L Bell; J Koach; S Smith; E Sekyere; W Thomas; M Norris; M Haber; D B Lovejoy; D R Richardson; G M Marshall
Journal:  Br J Cancer       Date:  2009-01-13       Impact factor: 7.640

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.